Citations are updated once a week. Recently added citations may not appear.
The suggestion is based on each study and bacteria having different weight based on a multitude of factors. For example, how severe a shift is seen.
| Context | Citation |
|---|---|
| Increases Pluralibacter - : Limosilactobacillus fermentum {L. fermentum} |
👶
Lactobacillus fermentum and Lactobacillus plantarum increased gut microbiota diversity and functionality, and mitigated Enterobacteriaceae, in a mouse model. Beneficial microbes (Benef Microbes ) Vol: 10 Issue 4 Pages: 413-424 Pub: 2019 Apr 19 Epub: 2019 Apr 8 Authors Linninge C , Xu J , Bahl MI , Ahrné S , Molin G , Publication |
| Decreases Pluralibacter - : Limosilactobacillus fermentum {L. fermentum} |
👶
Probiotic-Loaded Bacterial Cellulose as an Alternative to Combat Carbapenem-Resistant Bacterial Infections. Antibiotics (Basel, Switzerland) (Antibiotics (Basel) ) Vol: 13 Issue 11 Pages: Pub: 2024 Oct 25 Epub: 2024 Oct 25 Authors Gutiérrez-Fernández J , Cerezo-Collado L , Garcés V , Alarcón-Guijo P , Delgado-López JM , Dominguez-Vera JM , Html Article Publication |
| Decreases Pluralibacter - : Limosilactobacillus fermentum {L. fermentum} |
👶
Beneficial effects of GABA-producing potential probiotic Limosilactobacillus fermentum L18 of human origin on intestinal permeability and human gut microbiota. Microbial cell factories (Microb Cell Fact ) Vol: 22 Issue 1 Pages: 256 Pub: 2023 Dec 12 Epub: 2023 Dec 12 Authors Kaur S , Sharma P , Mayer MJ , Neuert S , Narbad A , Kaur S , Publication |
| 0 😁 | 😢 0 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]
